Skip to main content
openRxiv

Nebulized and intravenous enzyme replacement therapy in mice with mucopolysaccharidosis type II

Publication ,  Preprint
Shamoun, AJ; Reis, G; Ashley, M; Labilloy, A; Ferreira, LF
September 7, 2024

Duke Scholars

DOI

Publication Date

September 7, 2024
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shamoun, A. J., Reis, G., Ashley, M., Labilloy, A., & Ferreira, L. F. (2024). Nebulized and intravenous enzyme replacement therapy in mice with mucopolysaccharidosis type II. openRxiv. https://doi.org/10.1101/2024.09.03.611097
Shamoun, Alex J., Gisienne Reis, Malaica Ashley, Anatalia Labilloy, and Leonardo F. Ferreira. “Nebulized and intravenous enzyme replacement therapy in mice with mucopolysaccharidosis type II.” OpenRxiv, September 7, 2024. https://doi.org/10.1101/2024.09.03.611097.
Shamoun AJ, Reis G, Ashley M, Labilloy A, Ferreira LF. Nebulized and intravenous enzyme replacement therapy in mice with mucopolysaccharidosis type II. openRxiv. 2024.
Shamoun, Alex J., et al. “Nebulized and intravenous enzyme replacement therapy in mice with mucopolysaccharidosis type II.” OpenRxiv, 7 Sept. 2024. Crossref, doi:10.1101/2024.09.03.611097.
Shamoun AJ, Reis G, Ashley M, Labilloy A, Ferreira LF. Nebulized and intravenous enzyme replacement therapy in mice with mucopolysaccharidosis type II. openRxiv. 2024.

DOI

Publication Date

September 7, 2024